Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.3600
+0.0810 (29.03%)
At close: Oct 7, 2025, 4:00 PM EDT
0.4950
+0.1350 (37.50%)
After-hours: Oct 7, 2025, 7:59 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $18.13 million as of October 7, 2025. Its market cap has increased by 306.22% in one year.
Market Cap
18.13M
Enterprise Value
11.21M
1-Year Change
306.22%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since October 9, 2017, Processa Pharmaceuticals's market cap has decreased from $1.04B to $18.13M, a decrease of -98.25%. That is a compound annual growth rate of -39.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 14.05M | 386.52% |
| Dec 31, 2024 | 2.89M | -64.97% |
| Dec 29, 2023 | 8.24M | -53.15% |
| Dec 30, 2022 | 17.59M | -77.16% |
| Dec 31, 2021 | 77.01M | 10.52% |
| Dec 31, 2020 | 69.68M | -29.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |